Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancer.
Fabris
C
C
Basso
D
D
Meggiato
T
T
Del Favero
G
G
Piccoli
A
A
Fogar
P
P
Panozzo
M P
MP
Faggian
D
D
Naccarato
R
R
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002272:Carcinoembryonic Antigen / Q000378:metabolism*; D006801:Humans; D008107:Liver Diseases / Q000150:complications* / Q000276:immunology; D010190:Pancreatic Neoplasms / Q000276:immunology*; D010455:Peptides / Q000378:metabolism*; D019396:Tissue Polypeptide Antigen
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D010455:Peptides; D019396:Tissue Polypeptide Antigen